The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Top Cited Papers
Open Access
- 17 July 2020
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 182 (5), 1284-1294.e9
- https://doi.org/10.1016/j.cell.2020.07.012
Abstract
No abstract availableKeywords
Funding Information
- National Major Science and Technology Projects of China
This publication has 45 references indexed in Scilit:
- Crystal structure of a fully glycosylated HIV-1 gp120 core reveals a stabilizing role for the glycan at Asn262Proteins: Structure, Function, and Bioinformatics, 2015
- HemI: A Toolkit for Illustrating HeatmapsPLOS ONE, 2014
- A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralizationRetrovirology, 2013
- Airborne Transmission of Influenza A/H5N1 Virus Between FerretsScience, 2012
- The Highly Conserved Glycan at Asparagine 260 of HIV-1 gp120 Is Indispensable for Viral EntryOnline Journal of Public Health Informatics, 2011
- Quasispecies Theory and the Behavior of RNA VirusesPLoS Pathogens, 2010
- Two N-Linked Glycosylation Sites in the V2 and C2 Regions of Human Immunodeficiency Virus Type 1 CRF01_AE Envelope Glycoprotein gp120 Regulate Viral Neutralization Susceptibility to the Human Monoclonal Antibody Specific for the CD4 Binding DomainJournal of Virology, 2010
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- Removal of a Single N-Linked Glycan in Human Immunodeficiency Virus Type 1 gp120 Results in an Enhanced Ability To Induce Neutralizing Antibody ResponsesJournal of Virology, 2008
- A Single Mutation in Chikungunya Virus Affects Vector Specificity and Epidemic PotentialPLoS Pathogens, 2007